Status:
COMPLETED
Identification of Early Predictors of Fetomaternal Hemorrhage
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborating Sponsors:
National Center for Research Resources (NCRR)
New York Blood Center
Conditions:
Fetomaternal Hemorrhage
Neonatal Anemia
Eligibility:
All Genders
Up to 60 years
Brief Summary
Objectives: 1) To determine risk factors for fetomaternal hemorrhage. 2) To identify a cost-effective method to detect fetomaternal hemorrhage prior to significant fetal anemia. Significance/Backgrou...
Detailed Description
1. Introduction: The objective of this study is to identify candidate clinical predictors of fetomaternal hemorrhage (FMH) and to devise a screening strategy to identify pregnancies affected by th...
Eligibility Criteria
Inclusion
- Women admitted for term delivery (delivery between 37 0/7 and 41 6/7 weeks from the last menstrual period) to the Mount Sinai Medical Center
Exclusion
- Women carrying fetuses with known fetal anomaly.
- Women unable to complete the consent process due to likely precipitous delivery, severe labor discomfort, or fetal distress requiring immediate intervention.
Key Trial Info
Start Date :
May 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT01232387
Start Date
May 1 2011
End Date
September 1 2013
Last Update
September 20 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029